RAAVEN Trademark

Trademark Overview


On Monday, September 30, 2024, a trademark application was filed for RAAVEN with the United States Patent and Trademark Office. The USPTO has given the RAAVEN trademark a serial number of 79409327. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, December 16, 2025. This trademark is owned by Raaven Therapeutics AB. The RAAVEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research in the field of gene therapy; biological research, clinical research in the field of gene therapy, and medical research; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes in the area of cancerous diseases; medical research laboratory services; consultancy relating to scientific research in the field of pharmacogenetics; pharmaceutical research and development; consultancy in the field of pharmaceutical research; platform as a service (PaaS) featuring computer software platforms for use in screening and validation of AAV capsids within gene therapy research.
raaven

General Information


Serial Number79409327
Word MarkRAAVEN
Filing DateMonday, September 30, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, December 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific research in the field of gene therapy; biological research, clinical research in the field of gene therapy, and medical research; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research for medical purposes in the area of cancerous diseases; medical research laboratory services; consultancy relating to scientific research in the field of pharmacogenetics; pharmaceutical research and development; consultancy in the field of pharmaceutical research; platform as a service (PaaS) featuring computer software platforms for use in screening and validation of AAV capsids within gene therapy research.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRaaven Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events


Event DateEvent Description
Thursday, November 14, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 15, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Wednesday, April 16, 2025NON-FINAL ACTION WRITTEN
Thursday, April 17, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 18, 2025REFUSAL PROCESSED BY MPU
Wednesday, June 18, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 5, 2025REFUSAL PROCESSED BY IB
Tuesday, December 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED